Skip to content
Home/Companies/Biotech/XyloCor Therapeutics
XyloCor Therapeutics

XyloCor Therapeutics

Biotech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns XyloCor Therapeutics?

XyloCor Therapeutics is a French Biotech company, currently owned by Jeito Capital since 2024.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Jeito Capital
Investor
Jeito Capital
Jeito II · 2026 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.xylocor.com

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Adcendo
Active
BiotechDenmark· 2026
Alveus Therapeutics
Alveus Therapeutics
Active
BiotechUS· 2026
Bionyra Pharma
Active
BiotechFrance· 2026
Augustine Therapeutics
Augustine Therapeutics
Active
BiotechBelgium· 2025
Azafaros
Azafaros
Active
BiotechNetherlands· 2025
Callio Therapeutics
Active
BiotechUS· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns XyloCor Therapeutics?

XyloCor Therapeutics is currently owned by Jeito Capital, through Jeito II, since 2024.

When did Jeito Capital acquire XyloCor Therapeutics?

Jeito Capital acquired XyloCor Therapeutics in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue